AIOS GTM brain

category

market profile

• text: AIOS presents GLP-1 treatment as its current consumer growth wedge and autonomous prescribing as a future ambition requiring regulatory approval.
• text: UK consumers can compare many online pharmacies by medication, dose, price and support, increasing price sensitivity and switching.
• text: AIOS's long-term autonomous care vision remains distinct from its current licensed clinician-led service.

personas

• title: UK adult seeking medically supported weight management
  pains:

  • Wants to understand eligibility without an in-person appointment
  • Needs accessible clinical support, fair pricing and reliable medication delivery
• title: Existing weight-management patient comparing pharmacies
  pains:

  • Ongoing treatment costs vary by dose and provider
  • Switching requires confidence in continuity, support and prescribing review
• title: European healthcare payer evaluating future digital care
  pains:

  • Pressure on clinician capacity and cost of access
  • Needs evidence and regulatory authorization before adopting autonomous prescribing

icp

• text: UK adults seeking clinician-assessed prescription weight management; a prescriber determines individual suitability.
• text: European payers are a stated future target for autonomous care, contingent on regulatory approval rather than evidenced current customers.

message pillars

• text: Offer convenient initial assessment without an in-person visit.
• text: Build trust through licensed clinical oversight.
• text: Make care accessible beyond an appointment.
• text: Keep the prescribing decision with a clinician.

objections

• objection: Is prescription treatment suitable for me?
  response: A prescriber reviews the consultation and medical history to determine suitability; eligibility is not guaranteed.
• objection: Is the online service regulated?
  response: Verify Bolt's published GPhC registration and its clinical provider's CQC registration independently.
• objection: Does AI prescribe autonomously today?
  response: The company's autonomous system is a future goal requiring approval; Bolt states that UK clinicians review prescriptions.

competitors

• name: MedExpress
  why: UK online pharmacy offering weight-loss services to the same consumer audience.
• name: Hims & Hers
  why: Digital healthcare company offering competing UK weight-management services.
• name: Ro
  why: Virtual care and GLP-1 access provider, primarily a broader telehealth comparator.

keywords

• online weight loss clinic UK
• GLP-1 prescription UK
• online pharmacy weight management
• weight loss injection eligibility
• Mounjaro price comparison UK
• clinician led weight loss

voice

• Reassuring and clinician-led
• Convenience focused
• Direct about eligibility

signals

• text: A patient is comparing ongoing prices or seeking remote prescription weight-management support.
• text: A healthcare payer is exploring digitally delivered care at scale, subject to evidence and regulatory readiness.

hiring

• Dispenser
• Head of Expansion
• Head of Viral Social

pricing

motion

channels

• Website
• Referrals
• Social media

confidence

Founders

• name: Richie Cartwright
  title: Founder
  role: Founder
  bio: Building the world’s first full-stack AI doctor.